1-20 of 29
Adam Cohen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypomethylating agent with venetoclax versus hypomethylating agent alone in frontline management of myelodysplastic syndrome - impact of subgroups on clinical outcomes

Free
Guru Subramanian Guru Murthy, Yasmin Abaza, Somedeb Ball, Ramzi Abboud, Michael Haddadin, Jonathan Feld, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Adam Cohen-Nowak, Veronica Guerra, Hayley Hawkins, Asmita Shukla, Virginia Tan, Dominika Dulak, Reema Tawfiq, Emily Dworkin, Julian Weiss, Amber Feng, Jesus Gonzalez-Lugo, Prajwal Dhakal, Jessica Leonard, Charles Foucar, Talha Badar, Rory Shallis, Annie Im, Shyam Patel, Chenyu Lin, Anand Patel, Eric Winer, Ehab Atallah, Rami Komrokji
Journal: Blood
Blood (2025) 146 (Supplement 1): 239.
https://doi.org/10.1182/blood-2025-239
Published: 2025
Journal Articles

Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myeloma

Free
Beatrice Razzo, Rajshekhar Chakraborty, Hira Shaikh, Leonard Fiannaca, Sarah Girgis, Samantha Le, Sara Whittington, George Mellgard, David Lieberman, Ashkan Bigdeli, Jacquelyn Roth, Connnor Grady, Elizabeth Waugh, Francesca Nugent, Zachary Wolfe, Samer Al Hadidi, Carolina Schinke, Adam Binder, Christopher Strouse, Shivani Kapur, Sandra Susanibar-Adaniya, Adam Waxman, Dan Vogl, Adam Cohen, Edward Stadtmauer, Wei-Ting Hwang, Alfred Garfall
Journal: Blood
Blood (2025) 146 (Supplement 1): 5814.
https://doi.org/10.1182/blood-2025-5814
Published: 2025
Journal Articles

CCR5 blockade: A therapeutic approach to uncouple CART-BCMA expansion from CART-mediated immune toxicities.

Free
Luca Paruzzo, Matthew Ho, Julia Han Noll, Federico Stella, Ivan Cohen, Angel Ramirez-Fernandez, Adam Waxman, Shivani Kapur, Fang Chen, Andrew Huff, Danuta Jarocha, Owen Koucky, Caitlin Hopkins, Alex Dimitri, Maya Lavorando, Dan Vogl, John Scholler, Aoife Doto, John Everett, Frederic Bushman, Katherine Nathanson, Patrizia Porazzi, Edward Stadtmauer, Sandra Susanibar-Adaniya, Alfred Garfall, Adam Cohen, Joseph Fraietta, Marco Ruella
Journal: Blood
Blood (2025) 146 (Supplement 1): 5945.
https://doi.org/10.1182/blood-2025-5945
Published: 2025
Journal Articles

Delayed neurotoxicity, enterocolitis, and BCMA-CART-associated immune-related adverse events (CirAE)  are caused by CD4+ CAR T-cells

Free
Julia Han Noll, Matthew Ho, Luca Paruzzo, Federico Stella, Pooja Devi, Sonia Ndeupen, Gregory Chen, Ivan Cohen, Angel Ramirez-Fernandez, Adam Waxman, Shivani Kapur, Fang Chen, Rong Xu, Andrew Huff, Danuta Jarocha, Vrutti Patel, Audrey Bochi-Layec, Ranjani Ramasubramanian, Shan Liu, Riemke Bouvier, Vitor Souza, Heta Patel, Ziyu Li, Alberto Carturan, Peter Michener, Caitlin Hopkins, Owen Koucky, Janna Minehart, Alex Dimitri, Neel Nabar, Zainul Hasanali, Bryan Ciccarelli, Erik Williams, Robert Bartoszek, Maya Lavorando, Suyash Mohan, Vanessa Gonzalez, Patrizia Porazzi, Vijay Bhoj, Sokratis Apostolidis, Dan Vogl, David Porter, John Scholler, Caroline Diorio, Aoife Doto, John Everett, Frederic Bushman, Katherine Nathanson, Edward Stadtmauer, Sandra Susanibar-Adaniya, Alfred Garfall, Marco Ruella, Adam Cohen, Joseph Fraietta
Journal: Blood
Blood (2025) 146 (Supplement 1): 804.
https://doi.org/10.1182/blood-2025-804
Published: 2025
Journal Articles

Phase 2 study of cevostamab consolidation following BCMA CAR T cell therapy:  preliminary safety, efficacy, and correlative data from the “STEM” (Sequential T Cell-Engagement for Myeloma) trial

Free
Adam Cohen, Sandra Susanibar-Adaniya, Alfred Garfall, Dan Vogl, Shivani Kapur, Adam Waxman, Danielle Zubka, Wei-Ting Hwang, Cynthia Diaczynsky, Julia Han Noll, Matthew Ho, Luca Paruzzo, Bing Yi, Rong Xu, Elina Thai, Vanessa Gonzalez, Peter Michener, Marco Ruella, Joseph Fraietta, Edward Stadtmauer
Journal: Blood
Blood (2025) 146 (Supplement 1): 699.
https://doi.org/10.1182/blood-2025-699
Published: 2025
Journal Articles

Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study

Free
Nikita Dave, Shannon Gier, Marni Kessler, Miguel Rodriguez, Stefan Barta, Elise Chong, Adam Cohen, Noelle Frey, Saar Gill, Shannon Heck, Elizabeth Hexner, Nasheed Hossain, Shivani Kapur, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Pashna Munshi, Sunita Dwivedy Nasta, Alexander Perl, David Porter, Stephen Schuster, Edward Stadtmauer, Sandra Susanibar-Adaniya, Jakub Svoboda, Abby Togliatii, Dan Vogl, Adam Waxman, Daniel Wu, Shannon McCurdy
Journal: Blood
Blood (2025) 146 (Supplement 1): 7189.
https://doi.org/10.1182/blood-2025-7189
Published: 2025
Journal Articles

Chimeric antigen receptor T-cell therapy in patients with coexisting malignancy and autoimmune disease

Free
Luca Paruzzo, Riemke Bouvier, Bria Fulmer, Ivan Cohen, Elise Chong, Jakub Svoboda, Sunita Dwivedy Nasta, Daniel Landsburg, Vrutti Patel, Matthew Ho, Alberto Carturan, Federico Stella, Adam Waxman, Adam Cohen, Dan Vogl, Stefan Barta, Audrey Bochi-Layec, Patrizia Porazzi, Joseph Fraietta, Alfred Garfall, Vijay Bhoj, Edward Stadtmauer, David Porter, James Riley, Peter Merkel, Stephen Schuster, Jordan Carter, Sokratis Apostolidis, Sandra Susanibar-Adaniya, Marco Ruella
Journal: Blood
Blood (2025) 146 (Supplement 1): 4543.
https://doi.org/10.1182/blood-2025-4543
Published: 2025
Journal Articles

Rebuilding immunity: Kinetics and clinical impact of immune reconstitution after CAR T-cell therapy in multiple myeloma

Free
Heta Patel, Luca Paruzzo, Oxana Megherea, Matthew Ho, Thomas Luo, Dan Vogl, Shivani Kapur, Adam Waxman, Federico Stella, Alberto Carturan, Martina Pucillo, Antonio Imparato, Edward Stadtmauer, Alfred Garfall, Adam Cohen, Marco Ruella, Sandra Susanibar-Adaniya
Journal: Blood
Blood (2025) 146 (Supplement 1): 3995.
https://doi.org/10.1182/blood-2025-3995
Published: 2025
Journal Articles

Clinical Utilization and Outcomes of Hypomethylating Agents and Venetoclax in Patients with Myelodysplastic Syndrome - a Multicenter Retrospective Analysis

Free
Guru Subramanian Guru Murthy, Somedeb Ball, Jonathan Feld, Ramzi Abboud, Michael Haddadin, Shyam Ajay Patel, Ashwin Kishtagari, Hayley Hawkins, Veronica Guerra, Emily Dworkin, Reema K. Tawfiq, Dominika Dulak, Amber Feng, Christina Cotte, Adam Cohen-Nowak, Asmita Shukla, Suresh Kumar Balasubramanian, Eric S. Winer, Charles Foucar, Yasmin Abaza, Rory M. Shallis, Chenyu Lin, Talha Badar, Anand Ashwin Patel, Annie Im, Aniko Szabo, Ehab L. Atallah
Journal: Blood
Blood (2024) 144 (Supplement 1): 3206.
https://doi.org/10.1182/blood-2024-211623
Published: 2024
Journal Articles

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy

Free
Yan Tang, Wei Liu, Siddhant Kadu, Omar Johnson, Zainul S. Hasanali, Andre Kelly, Alexander Shestov, Raymone Pajarillo, Eli Greenblatt, Matthew Holmes, Li-Ping Wang, Natalie Shih, Roddy S. O’Connor, Marco Ruella, Alfred L. Garfall, David Allman, Dan T. Vogl, Adam Cohen, Carl H. June, Neil C. Sheppard
Journal: Blood
Blood (2024) 143 (2): 139–151.
https://doi.org/10.1182/blood.2022018658
Published: 2024
Includes: Supplemental data
Journal Articles

Characteristics and Outcomes of Younger Adult Patients (Pts) with Myelodysplastic Syndromes (MDS): A Multicenter Retrospective Study

Free
Yasmin Abaza, Zhuoer Xie, Madelyn Burkart, Talha Badar, Pinkal Desai, Rory M. Shallis, Anand Ashwin Patel, Adam Cohen-Nowak, Timothy S. Oh, Chelsea Walker, Neela Easwar, Tariq Kewan, Joseph Cannova, Kirsten Bell-Burdett, Najla H Al Ali, David A Sallman, Gail J. Roboz, Hetty E. Carraway, Amer M. Zeidan, Mrinal M. Patnaik, Jessica K. Altman, Rami S. Komrokji
Journal: Blood
Blood (2023) 142 (Supplement 1): 3232.
https://doi.org/10.1182/blood-2023-188328
Published: 2023
Journal Articles

Single-Agent Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma: Final Analysis of the DREAMM-2 Trial

Free
Ajay K. Nooka, Adam Cohen, Hans C. Lee, Ashraf Z. Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward Libby, Maria Chaudhry, Malin Hultcrantz, Martin Kortuem, Paul G. Richardson, Rakesh Popat, Douglas W. Sborov, Shawn Hakim, Eric Lewis, Bharat Bhushan, Boris Gorsh, Ira Gupta, Joanna Opalinska, Sagar Lonial
Journal: Blood
Blood (2022) 140 (Supplement 1): 7301–7303.
https://doi.org/10.1182/blood-2022-164877
Published: 2022
Journal Articles

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Free
Clinical Trials & Observations
Muzaffar H. Qazilbash, Neeraj Y. Saini, Soung-chul Cha, Zhe Wang, Edward A. Stadtmauer, Veerabhadran Baladandayuthapani, Heather Lin, Beryl Tross, Medhavi Honhar, Sheetal S. Rao, Kunhwa Kim, Michael Popescu, Szymon Szymura, Tiantian Zhang, Aaron Anderson, Qaiser Bashir, Elizabeth J. Shpall, Robert Z. Orlowski, Bruce L. Levine, Naseem Kerr, Alfred Garfall, Adam Cohen, Dan T. Vogl, Karen Dengel, Carl H. June, Richard Champlin, Larry W. Kwak
Journal: Blood
Blood (2022) 139 (9): 1289–1301.
https://doi.org/10.1182/blood.2020008493
Published: 2022
Includes: Supplemental data
Journal Articles

The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a Phase 2 Study

Free
Jatin J. Shah, M.D., Jeffrey A. Zonder, MD, Adam Cohen, MD, William Bensinger, MD, Jonathan L. Kaufman, MD, Robert Z. Orlowski, M.D., Ph.D., R. Donald Harvey, PharmD, Muneer H. Abidi, MD, Sheeba K. Thomas, MD, Duncan Walker, PhD, Brandi Hilder, Ann Marie Ptaszynski, MD, Sagar Lonial, MD
Journal: Blood
Blood (2012) 120 (21): 449.
https://doi.org/10.1182/blood.V120.21.449.449
Published: 2012
Journal Articles

Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients

Free
Adam Cohen, Lakshmanan Krishnamurti, MD, Susan E. Creary, MD
Journal: Blood
Blood (2012) 120 (21): 3538.
https://doi.org/10.1182/blood.V120.21.3538.3538
Published: 2012
Journal Articles

A Multicenter Phase II Clinical Trial of Rituximab Combined with Bortezomib (VELCADE®) Therapy for Untreated “High Tumor Burden” Indolent Non-Hodgkin Lymphoma (NHL)

Free
Andrew M. Evens, DO, MSc, Mitchell R Smith, MD, PhD, Izidore S Lossos, MD, Borko Jovanovic, PhD, Adam Cohen, MD, Jane N. Winter, MD, Steven T. Rosen, MD, FRCPA, Leo I. Gordon, MD
Journal: Blood
Blood (2012) 120 (21): 1642.
https://doi.org/10.1182/blood.V120.21.1642.1642
Published: 2012
Journal Articles

The Novel KSP Inhibitor ARRY-520 Demonstrates Single-Agent Activity in Refractory Myeloma: Results From a Phase 2 Trial in Patients with Relapsed/Refractory Multiple Myeloma (MM)

Free
Sagar Lonial, MD, Adam Cohen, Jeffrey Zonder, MD, William I Benzinger, MD, Jonathan L. Kaufman, MD, Robert Z. Orlowski, MD, PhD, R. Donald Harvey, PharmD, Raymond Alexanian, M.D., Sheeba K Thomas, M.D., Donna Weber, MD, Duncan Walker, PhD, Brandi Hilder, PhD, Ann Ptaszynski, Jatin J Shah, MD
Journal: Blood
Blood (2011) 118 (21): 2935.
https://doi.org/10.1182/blood.V118.21.2935.2935
Published: 2011
Journal Articles

ARRY-520 Shows Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Dose-Escalation Study

Free
Jatin J Shah, MD, Jeffrey Zonder, MD, Adam Cohen, Robert Z. Orlowski, MD, PhD, Raymond Alexanian, M.D., Sheeba K Thomas, M.D., Donna Weber, MD, Jonathan L. Kaufman, MD, R. Donald Harvey, PharmD, Duncan Walker, PhD, Kevin Litwiler, PhD, Sharon Karan, Brandi Hilder, Ann Marie Ptaszynski, MD, Sagar Lonial, MD
Journal: Blood
Blood (2011) 118 (21): 1860.
https://doi.org/10.1182/blood.V118.21.1860.1860
Published: 2011
Journal Articles

Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma

Free
Daniel E Fein, Hani Hassoun, MD, Raymond L. Comenzo, MD, Alex Lesokhin, Nikoletta Lendvai, MD, PhD, David Chung, MD, PhD, Adam Cohen, Michael A. Rosenzweig, MD, Danielle Chimento, Xiaoyu Jia, Stephen Nimer, Sergio Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2010) 116 (21): 1353.
https://doi.org/10.1182/blood.V116.21.1353.1353
Published: 2010
Journal Articles

A Phase I/II Trial of the KSP Inhibitor ARRY-520 In Relapsed/Refractory Multiple Myeloma

Free
Jatin J Shah, MD, Jeffrey A. Zonder, MD, Adam Cohen, Donna Weber, MD, Sheeba Thomas, MD, Michael Wang, MD, Jonathan L. Kaufman, MD, Steven Michael Burt, Duncan Walker, Burgess Freeman, Selena Armistead Rush, BS, Ann Ptaszynski, Robert Z. Orlowski, MD, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2010) 116 (21): 1959.
https://doi.org/10.1182/blood.V116.21.1959.1959
Published: 2010